Brief: SELLAS Life Sciences Q3 Net Income USD -7.108 Million
13/11/2024 21:15
Nov 13 (Reuters) - SELLAS Life Sciences Q3 operating expenses USD 7.329 million. * Q3 basic EPS USD -0.1 * Q3 operating income USD -7.329 million
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses